VanEck Associates Portfolio holdings
AUM
$88.3B
This Quarter Return
+15.53%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$38.7B
AUM Growth
+$38.7B
(+15%)
Cap. Flow
+$503M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
1,486
New
101
Increased
871
Reduced
409
Closed
62
Top Buys
| 1 |
Newmont
NEM
|
$138M |
| 2 |
Franco-Nevada
FNV
|
$132M |
| 3 |
B
Barrick Mining Corporation
B
|
$107M |
| 4 |
Dominion Energy
D
|
$93.8M |
| 5 |
Agnico Eagle Mines
AEM
|
$89.9M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$144M |
| 2 |
Charles Schwab
SCHW
|
$111M |
| 3 |
Schlumberger
SLB
|
$97.1M |
| 4 |
Blackrock
BLK
|
$94.5M |
| 5 |
Honeywell
HON
|
$94.2M |
Sector Composition
| 1 | Materials | 35.81% |
| 2 | Technology | 25.85% |
| 3 | Energy | 9% |
| 4 | Healthcare | 6.56% |
| 5 | Financials | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Unity
U
$16.5B
| $28.4M | 0.07% |
994,960
+39,633
| +4% | +$1.13M |
|
202
Piedmont Lithium
PLL
$159M
| $28.4M | 0.07% |
644,189
-74,860
| -10% | -$3.3M |
|
203
Cencora
COR
$57.2B
| $28.3M | 0.07% |
170,778
-15,049
| -8% | -$2.49M |
|
204
Takeda Pharmaceutical
TAK
$48B
| $27.8M | 0.07% |
1,785,206
-76,816
| -4% | -$1.2M |
|
205
Nike
NKE
$111B
| $26.7M | 0.07% |
227,986
-5,935
| -3% | -$694K |
|
206
AGCO
AGCO
$8.03B
| $26.6M | 0.07% |
191,837
-15,135
| -7% | -$2.1M |
|
207
Sanofi
SNY
$121B
| $26.5M | 0.07% |
547,031
-65,364
| -11% | -$3.17M |
|
208
GSK
GSK
$79.1B
| $26.1M | 0.07% |
743,913
-74,421
| -9% | -$2.62M |
|
209
Accenture
ACN
$160B
| $26M | 0.07% |
97,570
+1,824
| +2% | +$487K |
|
|
MRO
210
DELISTED
Marathon Oil Corporation
MRO
| $25.8M | 0.07% |
951,425
-5,804
| -0.6% | -$157K |
|
211
Viatris
VTRS
$12.3B
| $25.6M | 0.07% |
2,297,905
+300,343
| +15% | +$3.34M |
|
212
IQVIA
IQV
$31.7B
| $25.1M | 0.06% |
122,566
+21,570
| +21% | +$4.42M |
|
213
Southern Company
SO
$102B
| $24.9M | 0.06% |
349,033
+90,198
| +35% | +$6.44M |
|
|
SVM
214
Silvercorp Metals
SVM
$1.08B
| $24.8M | 0.06% |
8,366,073
+193,401
| +2% | +$572K |
|
215
Abbott
ABT
$230B
| $24.7M | 0.06% |
224,811
-3,697
| -2% | -$406K |
|
216
Main Street Capital
MAIN
$5.93B
| $24.5M | 0.06% |
662,192
+71,092
| +12% | +$2.63M |
|
217
Duke Energy
DUK
$95.2B
| $24.4M | 0.06% |
236,493
+60,277
| +34% | +$6.21M |
|
218
VanEck Merk Gold Trust
OUNZ
$1.87B
| $24.1M | 0.06% |
1,363,224
-66,248
| -5% | -$1.17M |
|
219
Teva Pharmaceuticals
TEVA
$21.3B
| $24.1M | 0.06% |
2,643,100
+348,658
| +15% | +$3.18M |
|
220
Shell
SHEL
$215B
| $23.8M | 0.06% |
418,250
-410
| -0.1% | -$23.3K |
|
221
Golub Capital BDC
GBDC
$3.95B
| $23.8M | 0.06% |
1,804,957
+56,869
| +3% | +$748K |
|
|
BDXB
222
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| $23.7M | 0.06% |
473,278
+4,809
| +1% | +$241K |
|
223
Prospect Capital
PSEC
$1.36B
| $23.7M | 0.06% |
3,384,568
+191,888
| +6% | +$1.34M |
|
224
Illumina
ILMN
$15.5B
| $23.5M | 0.06% |
116,302
+15,678
| +16% | +$3.17M |
|
225
Hercules Capital
HTGC
$3.53B
| $23.4M | 0.06% |
1,769,236
+87,293
| +5% | +$1.15M |
|